Camilla I. Svensson, PhD (Assistant Professor) performed her postgraduate research in molecular pathology with Prof. Tony L. Yaksh and Henry Powell at the University of California, San Diego (UCSD) in La Jolla, USA (2001–2005). She did postdoctoral studies with Prof. Gary Firestain at UCSD (2005–2008). After returning to Sweden as an independent investigator, her group was first to discover that an episode of joint inflammation can have a long-lasting effect on the sensory nervous system. Her current research activities span from in vitro molecular biological studies to in vivo behavioural pharmacology, centered on mechanisms of joint pain. Current research is focused on translational aspects of pain in arthritis and she is coordinating a research effort of five research groups (clinical and preclinical) that are investigating if joint inflammation can lead to a pain state that, from a neurochemical perspective, resembles nerve-injury induced pain, and if glia and glia-associated factors in the central nervous system contributes to the pain pathology in arthritis. This project is supported by the Swedish Association for Strategic Research. The Svensson group has recently embarked also on exploring pain mechnisms in other autoimmune diseases, focusing on the the role of antibodies in pain signaling. Finally, studies directed towards understanding the role of spinal toll-like receptors (TLR) and the role of endogenous TLR ligands in athritis induced pain are in progress and this work is supported by the Swedish Research Council. Dr. Svensson has received several awards, including the national “Future Research Leader” and the “Wallenberg Academy Fellow” awards and the “Early Career” award from the International Association for the Study of Pain. She has authored more than 45 peer-reviewd scientific articles and has 3 patents.
In GLORIA, Dr. Svensson’s research focuses on assessment of pain-like behaviour and effect of new compounds in rheumatoid, and osteoarthritis, and fibromyalgia; in vitro work in primary microglia and astrocyte cell cultures; and analysis of factors such as cytokines, chemokines and growth factors using quantitative real-time PCR and mesoscale ELISA in primary and cell culture samples.